Ramiro Ribeiro, the Chief Medical Officer of $EYPT, sold 2,437 shares of the company on 04-17-2026 for an estimated $36,555. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares of this class of stock. Following this trade, they now own 0 shares of this class of $EYPT stock.
$EYPT Insider Trading Activity
$EYPT insiders have traded $EYPT stock on the open market 10 times in the past 6 months. Of those trades, 1 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $EYPT stock by insiders over the last 6 months:
- ASSET MANAGEMENT, LP CORMORANT sold 60,000 shares for an estimated $942,240
- RAMIRO RIBEIRO (Chief Medical Officer) has made 0 purchases and 5 sales selling 52,578 shares for an estimated $875,603.
- NANCY LURKER has made 0 purchases and 3 sales selling 10,000 shares for an estimated $150,942.
- JAY S. DUKER (President and CEO) purchased 1,500 shares for an estimated $19,723
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$EYPT Hedge Fund Activity
We have seen 101 institutional investors add shares of $EYPT stock to their portfolio, and 52 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANUS HENDERSON GROUP PLC added 2,937,729 shares (+inf%) to their portfolio in Q4 2025, for an estimated $53,672,308
- CITADEL ADVISORS LLC removed 2,135,389 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $39,013,557
- BLACKROCK, INC. added 1,823,346 shares (+36.7%) to their portfolio in Q4 2025, for an estimated $33,312,531
- PARADIGM BIOCAPITAL ADVISORS LP added 1,686,110 shares (+84.1%) to their portfolio in Q4 2025, for an estimated $30,805,229
- SUVRETTA CAPITAL MANAGEMENT, LLC added 1,634,970 shares (+26.4%) to their portfolio in Q4 2025, for an estimated $29,870,901
- FEDERATED HERMES, INC. added 1,601,101 shares (+36.3%) to their portfolio in Q4 2025, for an estimated $29,252,115
- PARKMAN HEALTHCARE PARTNERS LLC added 1,088,033 shares (+inf%) to their portfolio in Q4 2025, for an estimated $19,878,362
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$EYPT Price Targets
Multiple analysts have issued price targets for $EYPT recently. We have seen 4 analysts offer price targets for $EYPT in the last 6 months, with a median target of $32.5.
Here are some recent targets:
- Yigal Nochomovitz from Citigroup set a target price of $35.0 on 03/09/2026
- Yi Chen from HC Wainwright & Co. set a target price of $30.0 on 03/05/2026
- Daniil Gataulin from Chardan Capital set a target price of $29.0 on 03/04/2026
- Lisa Walter from RBC Capital set a target price of $39.0 on 11/06/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
